Cefoperazone Sodium is the sodium salt form of cefoperazone and a semi-synthetic, broad-spectrum, beta-lactamase resistant, third-generation cephalosporin antibiotic with bactericidal activity. It is marketed by Pfizer under the name Cefobid. Cefoperazone sodium inhibits bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of bacterial cell walls. This results in a reduction of cell wall stability and causes cell lysis. It is one of few cephalosporin antibiotics effective in treating Pseudomonas bacterial infections which are otherwise resistant to these antibiotics.
Bacterial inhibitor Related Products:
Rifamycin sodium salt; Rifamycin; Moxifloxacin; Moxifloxacin HCL; Erythromycin Ethylsuccinate; Ceftezole; Ceftriaxone Sodium; Sulfacetamide sodium salt hydrate; Sulfachloropyridazine; Sulfachloropyridazine Sodium; Florfenicol; Furagin; Latamoxef sodium; Nimorazole; Ciprofloxacin hydrochloride hydrate; Ciprofloxacin; Cefoxitin Sodium; Azelaic acid; Erythromycin estolate